- Q1 2024 DURECT Corp Earnings Call TranscriptMay 13, 2024€0.95 (+1.60%)Earnings
- Q4 2023 DURECT Corp Earnings Call TranscriptMar 27, 2024€1.15 (+1.77%)Earnings
- Q3 2023 DURECT Corp Earnings Call TranscriptNov 13, 2023Earnings
- DURECT Corp Announces Topline Results from Phase 2b AHFIRM Trial of Larsucosterol TranscriptNov 07, 2023
- DURECT Corp at Cantor Fitzgerald Global Healthcare Conference TranscriptSep 27, 2023
- Q2 2023 DURECT Corp Earnings Call TranscriptAug 09, 2023€2.82 (-0.70%)Earnings
- Q1 2023 DURECT Corp Earnings Call TranscriptMay 08, 2023€4.3 (+10.82%)Earnings
- DURECT Corp at H.C. Wainwright BioConnect Investor Conference TranscriptMay 02, 2023
- DURECT Corp at Oppenheimer Healthcare Conference (Virtual) TranscriptMar 15, 2023
- Q4 2022 DURECT Corp Earnings Call TranscriptMar 07, 2023€4.56 (+2.24%)Earnings
- Q3 2022 DURECT Corp Earnings Call TranscriptNov 02, 2022€6.15 (-1.60%)Earnings
- Q2 2022 DURECT Corp Earnings Call TranscriptAug 04, 2022€5.7 (+8.57%)Earnings
- DURECT Corp Annual Shareholders Meeting TranscriptJun 15, 2022
- Q1 2022 DURECT Corp Earnings Call TranscriptMay 04, 2022€4.06 (+2.01%)Earnings
- Q4 2021 DURECT Corp Earnings Call TranscriptMar 07, 2022€5.6 (-3.45%)Earnings
- DURECT Corp To Discuss Agreement Call TranscriptDec 22, 2021
- Q3 2021 DURECT Corp Earnings Call TranscriptNov 02, 2021€10.9Earnings
- DURECT Corp at H C Wainwright NASH Investor Conference (Virtual) TranscriptOct 12, 2021
- Q2 2021 DURECT Corp Earnings Call TranscriptJul 29, 2021€11.8 (+2.61%)Earnings
- DURECT Corp Annual Shareholders Meeting TranscriptJun 15, 2021
- Q1 2021 DURECT Corp Earnings Call TranscriptMay 04, 2021€15.6 (-1.27%)Earnings
- Q4 2020 DURECT Corp Earnings Call TranscriptMar 04, 2021€17.6 (-7.85%)Earnings
- DURECT Corporation - Special Call TranscriptFeb 02, 2021
- DURECT Corporation - Special Call TranscriptNov 20, 2020
- Q3 2020 DURECT Corp Earnings Call TranscriptNov 02, 2020€15.4 (-0.65%)Earnings
- DURECT Corporation - Special Call TranscriptAug 27, 2020
- DURECT Corp DURECT Corporation Summary TranscriptAug 06, 2020
- Q2 2020 DURECT Corp Earnings Call TranscriptAug 03, 2020€17.2 (-1.15%)Earnings
- DURECT Corp Annual Shareholders Meeting TranscriptJun 17, 2020
- Q1 2020 DURECT Corp Earnings Call TranscriptMay 11, 2020€21 (+8.81%)Earnings
- Q4 2019 DURECT Corp Earnings Call TranscriptMar 03, 2020€17.5 (+6.71%)Earnings
- DURECT Corporation - Special Call TranscriptNov 12, 2019
- Q3 2019 DURECT Corp Earnings Call TranscriptNov 04, 2019€17 (+4.94%)Earnings
- Q2 2019 DURECT Corp Earnings Call TranscriptAug 01, 2019€9.64 (+0.88%)Earnings
- Q1 2019 DURECT Corp Earnings Call TranscriptMay 08, 2019€6.56 (-4.29%)Earnings
- DURECT Corporation Key Opinion Leader Call on NASH TranscriptApr 17, 2019
- DURECT Corporation Key Opinion Leader Call on Psoriasis TranscriptMar 29, 2019
- Q4 2018 DURECT Corp Earnings Call TranscriptMar 07, 2019€6.3 (-6.25%)Earnings
- DURECT Corporation - Special Call TranscriptFeb 27, 2019
Q1 2019 DURECT Corp Earnings Call Transcript
Good day and welcome to the DURECT Corporation First Quarter 2019 Earnings and Key Opinion Leader Call. Today's conference is being recorded.
At this time, I would like to turn the conference over to Mike Arenberg, Chief Financial Officer of DURECT. Please go ahead.
Good morning. This is Mike Arenberg, Chief Financial Officer of DURECT Corporation. Welcome to our first quarter 2019 earnings conference call. During the call, in addition to financial results, we will be reporting preliminary data from our ongoing Phase IIa clinical trial of DUR-928 in patients with alcoholic hepatitis, which we refer to as AH. We are fortunate to be joined today by 3 key opinion leaders in alcoholic hepatitis, Dr. Paul Kwo from Stanford, Dr. Steven Flamm from Northwestern and Dr. Tarek Hassanein from the University of California at San Diego.
I will provide a brief review of our financial results; and then Jim Brown, our President and CEO, will provide a business update on our programs; after which we will turn
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)